Monoclonal Antibodies in Cancer Therapy: Mechanisms, Successes and Limitations

被引：46
|
作者：
Coulson, A. [1 ]
Levy, A. [1 ]
Gossell-Williams, M. [1 ]
机构：
[1] Univ W Indies, Dept Basic Med Sci, Pharmacol Sect, Kingston 7, Jamaica
来源：
WEST INDIAN MEDICAL JOURNAL | 2014年 / 63卷 / 06期
关键词：
Antigenic targets; cancer therapy; clinical benefits; monoclonal antibodies; CHRONIC LYMPHOCYTIC-LEUKEMIA; BRENTUXIMAB VEDOTIN; COLORECTAL-CANCER; LYMPHOMA; RITUXIMAB; CHEMOTHERAPY; RADIOIMMUNOTHERAPY; TRASTUZUMAB; BEVACIZUMAB; INDUCTION;
D O I：
10.7727/wimj.2013.241
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Rituximab was the first chemotherapeutic monoclonal antibody (CmAb) approved for clinical use in cancer therapeutics in 1997 and has significantly improved the clinical outcomes in non-Hodgkin's lymphoma. Since then, numerous CmAbs have been developed and approved for the treatment of various haematologic and solid human cancers. In this review, the classification, efficacy and significantly reduced toxicity of CmAbs available for use in the United States of America are presented. Finally, the limitations of CmAbs and future considerations are explored.
引用
收藏
页码：650 / 654
页数：5
相关论文
共 50 条
  • [41] Status of bispecific monoclonal antibodies for cancer therapy
    Renner, C
    Pfreundschuh, M
    CLINICAL IMMUNOTHERAPEUTICS, 1996, 5 (01): : 30 - 39
  • [42] MONOCLONAL-ANTIBODIES IN CANCER-THERAPY
    RIETHMULLER, G
    SCHNEIDERGADICKE, E
    JOHNSON, JP
    CURRENT OPINION IN IMMUNOLOGY, 1993, 5 (05) : 732 - 739
  • [43] The potential of monoclonal antibodies for colorectal cancer therapy
    Heidari, Fatemeh
    Madadi, Soheil
    Alizadeh, Neda
    Alimardani, Mohammad Hossein
    Safari, Armin
    Armand, Mohammad Hossein
    Pishgahzadeh, Elahe
    Soleimani, Meysam
    MEDICAL ONCOLOGY, 2023, 40 (09)
  • [44] MONOCLONAL-ANTIBODIES IN CANCER-THERAPY
    MELLSTEDT, H
    CURRENT OPINION IN IMMUNOLOGY, 1990, 2 (05) : 708 - 713
  • [45] The potential of monoclonal antibodies for colorectal cancer therapy
    Fatemeh Heidari
    Soheil Madadi
    Neda Alizadeh
    Mohammad Hossein Alimardani
    Armin Safari
    Mohammad Hossein Armand
    Elahe Pishgahzadeh
    Meysam Soleimani
    Medical Oncology, 40
  • [46] Application of Monoclonal Antibodies as Cancer Therapy in Solid Tumors
    Dienstmann, Rodrigo
    Markman, Ben
    Tabernero, Josep
    CURRENT CLINICAL PHARMACOLOGY, 2012, 7 (02): : 137 - 145
  • [47] Targeted cancer therapy using radiolabeled monoclonal antibodies
    Bethge, WA
    Sandmaier, BM
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2005, 4 (04) : 393 - 405
  • [48] Combination Therapy with monoclonal Antibodies for the Treatment of Colon Cancer
    Di Lellis, Maddalena Angela
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2019, 57 (07): : 826 - +
  • [49] MONOCLONAL-ANTIBODIES IN THE DIAGNOSIS, DETECTION AND THERAPY OF CANCER
    BALDWIN, RW
    PROCEEDINGS OF THE ROYAL SOCIETY OF EDINBURGH SECTION B-BIOLOGICAL SCIENCES, 1982, 81 : 261 - 276
  • [50] LABELED MONOCLONAL-ANTIBODIES FOR CANCER-THERAPY
    KROHN, KA
    ALI, SA
    EARY, JF
    BADGER, CC
    NELP, WB
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1989, 197 : 72 - NUCL
12345